<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02765477</url>
  </required_header>
  <id_info>
    <org_study_id>HSR 15-4101</org_study_id>
    <nct_id>NCT02765477</nct_id>
  </id_info>
  <brief_title>Paced Electrocardiogram Requiring Fast Emergent Coronary Therapy (PERFECT) Study</brief_title>
  <acronym>PERFECT</acronym>
  <official_title>Paced Electrocardiogram Requiring Fast Emergent Coronary Therapy (PERFECT) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hennepin County Medical Center, Minneapolis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hennepin County Medical Center, Minneapolis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The number of patients with cardiovascular implantable electronic devices (CIED), including
      ventricular pacemakers, continues to increase. However, there are no accurate
      electrocardiographic (ECG) criteria to diagnose acute myocardial infarction (AMI), even if
      due to acute coronary occlusion (ACO), with a ventricular pacemaker in situ. In this
      retrospective, multicenter, case-control study the investigators will examine ECG criteria to
      diagnose ACO in patients with ventricular paced rhythms. During this process, the
      investigators will also create a database from which investigators will be able to answer
      multiple additional questions on this population of patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND Diagnosis and management of ACO (the anatomic substrate for ST-elevation
      myocardial infarction) is time sensitive. Diagnosis necessitates emergent reperfusion
      therapy. An important predictor of death from ACO includes time to reperfusion.1 Delays in
      reperfusion therapy, including primary percutaneous coronary intervention (PCI) or
      fibrinolysis, are associated with worse 30-day and 1-year mortality. American Heart
      Association (AHA) guidelines for treatment of ACO recommend that the first medical contact to
      device time be less than 120 minutes in patients who have no contraindications to treatment.2
      Though cardiac biomarkers are helpful in making the diagnosis in uncertain cases, the time
      sensitive nature of intervention for ACO precludes their use to direct emergent reperfusion
      therapy. Furthermore, biomarkers do not diagnose ACO but rather any AMI, including those
      without occlusion that do not need emergent intervention.

      The &quot;traditional&quot; ECG diagnosis of ACO, which includes ST-elevation cutoffs based upon age
      and sex, excludes patients with ventricular paced rhythm (VPR).3 The small field of research
      on the topic of ACO in VPR has extrapolated and analyzed data from patients with left bundle
      branch block (LBBB). That is because VPR with right ventricular pacing and LBBB both result
      in depolarization from right to left through myocardium (not through conducting fibers) and
      thus result in similar ECG findings (e.g. wide QRS, delayed onset of depolarization, and
      abnormal repolarization with &quot;discordant&quot; [in the opposite direction of the QRS] T-waves and
      ST-segment deviation). In the presence of known LBBB, AHA guidelines recommend using the
      Sgarbossa criteria to make the diagnosis of ACO.4 Sgarbossa et al. proposed requiring at
      least 3 points from the following criteria for the diagnosis of acute myocardial infarction
      in the presence of LBBB: (1) concordant ST-segment elevation of 1 mm (0.1 mV) in at least 1
      lead (5 points), (2) concordant ST-segment depression of at least 1 mm in leads V1 to V3 (3
      points), or (3) excessively discordant ST-segment elevation, defined as greater than or equal
      to 5 mm of ST-segment elevation when the QRS complex is negative (2 points). There have been
      only a handful of evaluations of Sgarbossa's criteria in VPR, with variable methodologies and
      patient populations; sensitivities in the studies ranged from 10-53% and specificities ranged
      from 84-99%.5,6 Neither study used angiographic endpoints, but only used biomarker
      definitions of AMI; one study used a very flawed biomarker definition with no adjudication.
      Thus, the number of occlusions is entirely unknown and probably very small.

      For LBBB, Smith et al. derived and validated a &quot;modified Sgarbossa rule&quot; in which they
      replaced Sgarbossa's third criterion (excessively discordant ST elevation as defined by 5 mm)
      with a proportion-based criterion (defined by &gt; 25% of the previous S-wave) (see Table 1).
      This rule resulted in much higher sensitivity and accuracy for diagnosis of ACO than the
      original Sgarbossa.7,8

      Table 1: MODIFIED SGARBOSSA CRITERIA

        1. ST-segment elevation &gt;= 1 mm and concordant with the QRS in any lead

        2. ST-segment depression &gt;= 1 mm and concordant with the QRS in any of leads V1- V3

        3. Proportionally excessive discordant ST-segment elevation in at least one lead, as
           defined by ST/S (&lt;/= -0.25) with at least 1 mm of STE

      The modified Sgarbossa criteria have never been evaluated in patients with VPR and very few
      additional criteria have ever been evaluated. To our knowledge, no criteria have been
      evaluated using an angiographic outcome, the only outcome relevant to guiding emergency
      reperfusion therapy. The primary purpose of this study will be to investigate the diagnostic
      performance of selected ECG criteria for the diagnosis of ACO in VPR. Through the process of
      answering this question, a database will be formed to answer multiple additional questions on
      this patient population that is underrepresented in clinical trials.

      STUDY DESIGN The primary analysis will be designed as a multicenter, retrospective
      case-control study. Additionally, data will be collected to create a database of
      de-identified patient information that will allow researchers to investigate numerous
      additional questions.

      Study sites will include Hennepin County Medical Center (HCMC, the lead site) and academic
      and community centers (study sites) located internationally. Because AMI was redefined in
      2007 by a rise and/or fall of troponin, with at least one value above the 99% reference
      value,9 our study will only include subjects that presented from January 1, 2008 through
      December 31, 2015.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and Specificity of Modified Sgarbossa Criteria for Diagnosis of Acute Coronary Occlusion in the Setting of Ventricular Paced Rhythm in Patients with Potential Ischemic Symptoms</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and Specificity of the modified Sgarbossa criteria with criterion #2 extended from electrocardiogram leads V1-V3 to leads V1-V6</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance characteristics of the modified Sgarbossa criteria using a maximum ST/S ratio of -0.20, and of -0.30, instead of -0.25</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance characteristics of absolute ECG millimeter measurements of ST discordance (including both discordant ST elevation and ST depression), using various ratio cutoffs (e.g. -0.2, -0.25, -0.3).</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance characteristics of 0.5 mm (vs. 1 mm) concordant ST-deviation.</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance characteristics of non-concave ST-morphology</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean QRS amplitude of occlusion vs. no occlusion groups. Plot receiver-operator curve for QRS amplitude</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Find mean T-wave amplitude in occlusion vs. no occlusion groups. Plot ROC curves for T/QRS ratio between groups.</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean QTc, JTc, and TpTe in occlusion vs no occlusion groups, and plot ROC curves for QTc, JTc, and TpTe</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multivariate regression model including measurements of concordant and discordant ST elevation or depression, and of QRS amplitude, all in millimeters, and of repolarization time, in milliseconds.</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Angiogram Cohort w Acute Coronary Occlusion</arm_group_label>
    <description>Inclusion Criteria: Angiogram Cohort. Patients who present 1) directly through the study site Emergency Department (ED) OR 2) as a transfer or referral patient from the ED of another institution OR 3) as a direct admission to the study site's Catheterization Laboratory by an ambulance service, who also met the following criteria: 1.Underwent urgent or emergent coronary angiography during the index presentation for suspected ischemic symptoms (including but not limited to chest pain [CP] and/or shortness of breath [SOB]) AND 2. Had a VPR ECG recorded during the index presentation prior to the angiogram AND 3. Had sufficient troponins to rule in or rule out acute myocardial injury, per the study site's institutional protocol. From this Angiogram Cohort, a group of patients will be identified who had angiographic evidence of ACO, defined as an acute lesion with TIMI flow 0 or 1 when evaluated by an experienced study-site adjudicator.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-ACO Angiogram Cohort</arm_group_label>
    <description>Inclusion Criteria: Angiogram Cohort. Each study site will first identify adult patients (age 18 years or older) who presented to the study site 1) directly through the study site ED OR 2) as a transfer or referral patient from the ED of another institution OR 3) as a direct admission to the study site's Catheterization Laboratory by an ambulance service, who also met the following criteria: 1. Underwent coronary angiography during the index presentation for suspected ischemic symptoms (including but not limited to CP and/or SOB AND 2. Had a VPR ECG recorded during the index presentation prior to the angiogram AND 3. Had sufficient troponins to rule in or rule out acute myocardial injury, per the study site's institutional protocol. From this Angiogram Cohort, those who had TIMI-2 or greater flow will be identified for several research questions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Random ED Sample w Paced Rhythm but No AMI</arm_group_label>
    <description>Each site will select a random sample of all adult patients who present to the ED (or by ambulance directly to the Catheterization Lab) with suspected ischemic symptoms and a VPR ECG.
Each study site will randomly select 5 unique encounters for every one 1 ACO subject identified by the site. If a study site identifies no ACO subjects, they will randomly select 30 unique encounters.
Study subjects who are included as subjects in the Angiogram Cohort (data set #1, above) and who are also selected as part of the random sample (data set #2) will be identified in REDCap as subjects for analysis in both groups, but their data will be submitted only once.
The primary control group selected from this search will be all patients in this group who do not meet criteria for acute myocardial injury, as defined by 1) all troponins below the 99th percentile or 2) Peak troponin &lt; 3x the upper limit of normal AND no rise and/or fall of &gt; 30%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ED Patients w Paced Rhythm Without AMI excluded</arm_group_label>
    <description>Each site will select a random sample of all adult patients who present to the ED (or by ambulance directly to the Catheterization Lab) with suspected ischemic symptoms and a VPR ECG.
Each study site will randomly 5 unique encounters for every 1 ACO subject identified by the site. If a study site identifies no ACO subjects, they will randomly select 30 unique encounters.
Study subjects who are included as subjects in the Angiogram Cohort (data set #1, above) and who are also selected as part of the random sample (data set #2) will be identified in REDCap as subjects for analysis in both groups, but their data will be submitted only once.
The secondary control group will include patients in this group in whom Acute MI cannot be excluded because they either have at least 1 troponin &gt; 3x the upper limit of normal or they have at least 1 troponin between 1x and 3x the ULN AND have a rise and/or fall of at least 30%.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        I. Adults who presented either 1) directly through the Emergency Department (ED), 2) as a
        transfer or referral patient, or 3) as a direct ambulance admission to the Catheterization
        Laboratory, who also:

          1. Underwent urgent or emergent coronary angiography during the index presentation for
             suspected ischemic symptoms, and

          2. Had a ventricular paced rhythm (VPR) on the ECG

          3. Had sufficient troponins to rule in or rule out acute myocardial injury, per the study
             site's institutional protocol.

        II. Next, each study site will identify all adult ED patients with a VPR ECG recorded
        during the index presentation who presented with suspected ischemic symptoms. Simple random
        selection will be used to identify subjects from this population. There may be overlap
        between this group and the angiogram group above and this will be considered at the data
        analysis stage (see Procedures Manual for more detail).

        The first group will not be a probability sample, but the second group will be.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 year old at least, ischemic symptoms (e.g., chest pain, shortness of breath, etc.),
             ventricular paced rhythm on the Electrocardiogram (ECG).

        Exclusion Criteria:

          -  Exclusion from Primary Analysis:

               1. Extreme tachycardia (heart rate &gt; 130 bpm) at the time of presentation

               2. Severe hypertension (diastolic blood pressure &gt; 120 mmHg) at the time of
                  presentation

               3. Respiratory failure (defined as need for positive pressure ventilation) due to
                  pulmonary edema at the time of presentation.

               4. Hyperkalemia (serum potassium &gt; 5.5 mEq/L) at the time of presentation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth W Dodd, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Hennepin County Medical Center, Minneapolis, MN</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen W Smith, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hennepin County Medical Center, Minneapolis, MN</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Deborah L Zvosec, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Minneapolis Medical Research Foundation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rehan Karim, MBBS</last_name>
    <role>Study Chair</role>
    <affiliation>Hennepin County Medical Center, Minneapolis, MN</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Louise Cullen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Royal Brisbane and Women's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Body, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>The University of Manchester</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephen W Smith, M.D.</last_name>
    <phone>612-875-4226</phone>
    <email>smith253@umn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Deborah L Zvosec, Ph.D.</last_name>
    <phone>612-432-1677</phone>
    <email>Deborah.Zvosec@hcmed.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hennepin County Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen W Smith, MD</last_name>
      <phone>612-875-4226</phone>
      <email>Stephen.Smith@hcmed.org</email>
    </contact>
    <contact_backup>
      <last_name>Kenneth Dodd, MD</last_name>
      <phone>612-716-7085</phone>
      <email>Kenneth.Dodd@hcmed.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions, O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Jan 29;61(4):e78-140. doi: 10.1016/j.jacc.2012.11.019. Epub 2012 Dec 17.</citation>
    <PMID>23256914</PMID>
  </reference>
  <reference>
    <citation>Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasch√© P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J. 2012 Oct;33(20):2551-67. doi: 10.1093/eurheartj/ehs184. Epub 2012 Aug 24.</citation>
    <PMID>22922414</PMID>
  </reference>
  <reference>
    <citation>Sgarbossa EB. Recent advances in the electrocardiographic diagnosis of myocardial infarction: left bundle branch block and pacing. Pacing Clin Electrophysiol. 1996 Sep;19(9):1370-9. Review.</citation>
    <PMID>8880802</PMID>
  </reference>
  <reference>
    <citation>Jaffe AS. Third universal definition of myocardial infarction. Clin Biochem. 2013 Jan;46(1-2):1-4. doi: 10.1016/j.clinbiochem.2012.10.036. Epub 2012 Nov 2.</citation>
    <PMID>23127386</PMID>
  </reference>
  <results_reference>
    <citation>Nielsen PH, Terkelsen CJ, Nielsen TT, Thuesen L, Krusell LR, Thayssen P, Kelbaek H, Abildgaard U, Villadsen AB, Andersen HR, Maeng M; Danami-2 Investigators. System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial). Am J Cardiol. 2011 Sep 15;108(6):776-81. doi: 10.1016/j.amjcard.2011.05.007. Epub 2011 Jul 15.</citation>
    <PMID>21757183</PMID>
  </results_reference>
  <results_reference>
    <citation>Sgarbossa EB, Pinski SL, Barbagelata A, Underwood DA, Gates KB, Topol EJ, Califf RM, Wagner GS. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med. 1996 Feb 22;334(8):481-7. Erratum in: N Engl J Med 1996 Apr 4;334(14):931.</citation>
    <PMID>8559200</PMID>
  </results_reference>
  <results_reference>
    <citation>Maloy KR, Bhat R, Davis J, Reed K, Morrissey R. Sgarbossa Criteria are Highly Specific for Acute Myocardial Infarction with Pacemakers. West J Emerg Med. 2010 Sep;11(4):354-7.</citation>
    <PMID>21079708</PMID>
  </results_reference>
  <results_reference>
    <citation>Meyers HP, Limkakeng AT Jr, Jaffa EJ, Patel A, Theiling BJ, Rezaie SR, Stewart T, Zhuang C, Pera VK, Smith SW. Validation of the modified Sgarbossa criteria for acute coronary occlusion in the setting of left bundle branch block: A retrospective case-control study. Am Heart J. 2015 Dec;170(6):1255-64. doi: 10.1016/j.ahj.2015.09.005. Epub 2015 Sep 24.</citation>
    <PMID>26678648</PMID>
  </results_reference>
  <results_reference>
    <citation>Smith SW, Dodd KW, Henry TD, Dvorak DM, Pearce LA. Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule. Ann Emerg Med. 2012 Dec;60(6):766-76. doi: 10.1016/j.annemergmed.2012.07.119. Epub 2012 Aug 31. Erratum in: Ann Emerg Med. 2013 Oct;62(4):302.</citation>
    <PMID>22939607</PMID>
  </results_reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2016</study_first_submitted>
  <study_first_submitted_qc>May 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2016</study_first_posted>
  <last_update_submitted>November 29, 2016</last_update_submitted>
  <last_update_submitted_qc>November 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hennepin County Medical Center, Minneapolis</investigator_affiliation>
    <investigator_full_name>Stephen W. Smith</investigator_full_name>
    <investigator_title>Faculty Emergency Physician, Professor of Emergency Medicine</investigator_title>
  </responsible_party>
  <keyword>Acute myocardial infarction</keyword>
  <keyword>ST Elevation Myocardial Infarction</keyword>
  <keyword>Acute Coronary Occlusion</keyword>
  <keyword>Electrocardiogram</keyword>
  <keyword>Ventricular Paced Rhythm</keyword>
  <keyword>Modified Sgarbossa Criteria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

